Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Inventory Average (2016 - 2025)

Fortress Biotech has reported Inventory Average over the past 10 years, most recently at $11.2 million for Q4 2025.

  • Quarterly results put Inventory Average at $11.2 million for Q4 2025, down 16.06% from a year ago — trailing twelve months through Dec 2025 was $11.2 million (down 16.06% YoY), and the annual figure for FY2025 was $12.8 million, up 1.65%.
  • Inventory Average for Q4 2025 was $11.2 million at Fortress Biotech, down from $12.7 million in the prior quarter.
  • Over the last five years, Inventory Average for FBIO hit a ceiling of $16.1 million in Q2 2022 and a floor of $1.8 million in Q1 2021.
  • Median Inventory Average over the past 5 years was $12.7 million (2023), compared with a mean of $11.9 million.
  • Biggest five-year swings in Inventory Average: soared 1046.79% in 2021 and later dropped 27.76% in 2023.
  • Fortress Biotech's Inventory Average stood at $10.7 million in 2021, then surged by 36.85% to $14.7 million in 2022, then decreased by 27.76% to $10.6 million in 2023, then rose by 25.92% to $13.4 million in 2024, then decreased by 16.06% to $11.2 million in 2025.
  • The last three reported values for Inventory Average were $11.2 million (Q4 2025), $12.7 million (Q3 2025), and $13.0 million (Q2 2025) per Business Quant data.